Acute peripheral administration of synthetic human GLP-1 (7–36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: a potential role for …

Acute peripheral administration of synthetic human GLP-1 (7–36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: a potential role for …

C Daousi, JH Pinkney, J Cleator, JP Wilding… - Regulatory peptides, 2013 - Elsevier

... Obestatin and ghrelin were measured with commercial EIA kits purchased from Bachem UK. ...
IL-6 in obese patients with T2DM, whilst other adipokines and gut-brain peptides remained
unchanged ... Prior to our study the acute effects of the natural GLP-1 peptide on circulating IL-6 ...

Peptide synthesis, peptide modification and peptide library synthesis, please contact:

Eva He

eva@pepmic.com

Pepmic Co., Ltd

www.pepmic.com